BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1829430)

  • 1. Expression of human Cu-Zn superoxide dismutase gene in transgenic mice: model for gene dosage effect in Down syndrome.
    Ceballos I; Nicole A; Briand P; Grimber G; Delacourte A; Flament S; Blouin JL; Thevenin M; Kamoun P; Sinet PM
    Free Radic Res Commun; 1991; 12-13 Pt 2():581-9. PubMed ID: 1829430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome.
    Ceballos-Picot I; Nicole A; Briand P; Grimber G; Delacourte A; Defossez A; Javoy-Agid F; Lafon M; Blouin JL; Sinet PM
    Brain Res; 1991 Jun; 552(2):198-214. PubMed ID: 1717112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic mice overexpressing the human Cu/Zn-SOD gene: ultrastructural studies of a premature thymic involution model of Down's syndrome (trisomy 21).
    Nabarra B; Casanova M; Paris D; Nicole A; Toyama K; Sinet PM; Ceballos I; London J
    Lab Invest; 1996 Mar; 74(3):617-26. PubMed ID: 8600312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transgenic mice overexpressing copper-zinc superoxide dismutase: a model for the study of radical mechanisms and aging].
    Ceballos-Picot I
    C R Seances Soc Biol Fil; 1993; 187(3):308-23. PubMed ID: 8019910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down syndrome clinical symptoms are manifested in transfected cells and transgenic mice overexpressing the human Cu/Zn-superoxide dismutase gene.
    Groner Y; Elroy-Stein O; Avraham KB; Yarom R; Schickler M; Knobler H; Rotman G
    J Physiol (Paris); 1990; 84(1):53-77. PubMed ID: 1972759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular clones and transgenic mice overexpressing copper-zinc superoxide dismutase: models for the study of free radical metabolism and aging.
    Ceballos-Picot I; Nicole A; Sinet PM
    EXS; 1992; 62():89-98. PubMed ID: 1450608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell damage by excess CuZnSOD and Down's syndrome.
    Groner Y; Elroy-Stein O; Avraham KB; Schickler M; Knobler H; Minc-Golomb D; Bar-Peled O; Yarom R; Rotshenker S
    Biomed Pharmacother; 1994; 48(5-6):231-40. PubMed ID: 7999984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome.
    Epstein CJ; Avraham KB; Lovett M; Smith S; Elroy-Stein O; Rotman G; Bry C; Groner Y
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8044-8. PubMed ID: 2960971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and characterization of Siamese crocodile (Crocodylus siamensis) copper, zinc superoxide dismutase (CSI-Cu,Zn-SOD) gene.
    Sujiwattanarat P; Pongsanarakul P; Temsiripong Y; Temsiripong T; Thawornkuno C; Uno Y; Unajak S; Matsuda Y; Choowongkomon K; Srikulnath K
    Comp Biochem Physiol A Mol Integr Physiol; 2016 Jan; 191():187-195. PubMed ID: 26523498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical symptoms of Down syndrome are manifested in transgenic mice overexpressing the human Cu/Zn-superoxide dismutase gene.
    Groner Y; Avraham KB; Schickler M; Yarom R; Knobler H
    Prog Clin Biol Res; 1990; 360():233-62. PubMed ID: 2147288
    [No Abstract]   [Full Text] [Related]  

  • 11. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus.
    Furuta A; Price DL; Pardo CA; Troncoso JC; Xu ZS; Taniguchi N; Martin LJ
    Am J Pathol; 1995 Feb; 146(2):357-67. PubMed ID: 7856748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative damage and antioxidant defences: relevance to Down's syndrome and familial amyotrophic lateral sclerosis.
    Lee M; Hyun D; Jenner P; Halliwell B
    J Neurochem; 2001 Feb; 76(4):957-65. PubMed ID: 11181815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down's syndrome: morphological remodelling and increased complexity in the neuromuscular junction of transgenic CuZn-superoxide dismutase mice.
    Avraham KB; Sugarman H; Rotshenker S; Groner Y
    J Neurocytol; 1991 Mar; 20(3):208-15. PubMed ID: 1828079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superoxide dismutase, catalase, and glutathione peroxidase activities in copper/zinc-superoxide dismutase transgenic mice.
    Przedborski S; Jackson-Lewis V; Kostic V; Carlson E; Epstein CJ; Cadet JL
    J Neurochem; 1992 May; 58(5):1760-7. PubMed ID: 1560230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal mossy fiber changes in mice transgenic for the human copper-zinc superoxide dismutase gene.
    Barkats M; Bertholet JY; Venault P; Ceballos-Picot I; Nicole A; Phillips J; Moutier R; Roubertoux P; Sinet PM; Cohen-Salmon C
    Neurosci Lett; 1993 Sep; 160(1):24-8. PubMed ID: 8247326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premature thymic involution, observed at the ultrastructural level, in two lineages of human-SOD-1 transgenic mice.
    Nabarra B; Casanova M; Paris D; Paly E; Toyoma K; Ceballos I; London J
    Mech Ageing Dev; 1997 Jun; 96(1-3):59-73. PubMed ID: 9223111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of manganese superoxide dismutase is not altered in transgenic mice with elevated level of copper-zinc superoxide dismutase.
    White CW; Nguyen DH; Suzuki K; Taniguchi N; Rusakow LS; Avraham KB; Groner Y
    Free Radic Biol Med; 1993 Dec; 15(6):629-36. PubMed ID: 8138189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red cell superoxide dismutase, glutathione peroxidase and catalase in Down syndrome patients with and without manifestations of Alzheimer disease.
    Percy ME; Dalton AJ; Markovic VD; McLachlan DR; Hummel JT; Rusk AC; Andrews DF
    Am J Med Genet; 1990 Apr; 35(4):459-67. PubMed ID: 2139757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down's syndrome: abnormal neuromuscular junction in tongue of transgenic mice with elevated levels of human Cu/Zn-superoxide dismutase.
    Avraham KB; Schickler M; Sapoznikov D; Yarom R; Groner Y
    Cell; 1988 Sep; 54(6):823-9. PubMed ID: 2970304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant and oxidative status in tissues of manganese superoxide dismutase transgenic mice.
    Ibrahim W; Lee US; Yen HC; St Clair DK; Chow CK
    Free Radic Biol Med; 2000 Feb; 28(3):397-402. PubMed ID: 10699751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.